Informal Request for ATI Records Previously Released

Organization: Health Canada

Year: 2023

Month: July

Request Number: A-2017-000315

Request Summary: The most current Canadian Risk Management Plan (RMP) or Canadian Addendum to the RMP and Canadian RMP review report for Avastin (Bevacizumab) by Hoffmann-La Roche Limited, Drug Identification Number (DIN): 02270994

Disposition: Disclosed in part

Number of pages: 392

Date modified: